Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerResumen de Investigación
Analyzed using Evidence Intelligence™
QCC Model Enhances Diabetes Management
Última actualización 18 de julio de 2026
Key finding
The EG demonstrated significant improvements in fasting C-peptide levels compared to the RG.
The study evaluated the QCC nursing model's impact on blood glucose control in Type 2 diabetes patients, finding significant improvements in various metabolic markers.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Risk of bias
Some Concerns
Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.
Plain-language summary
What this paper says
A plain-language read of the study’s main message and where it applies.
Study focus
The study evaluated the QCC nursing model's impact on blood glucose control in Type 2 diabetes patients, finding significant improvements in various metabolic markers.
Clinical relevance
Effective management of blood glucose levels is crucial for Type 2 diabetes patients to prevent complications. The QCC nursing model not only improved metabolic outcomes but also enhanced patient satisfaction, indicating a holistic approach to diabetes care that could lead to better long-term health outcomes.
Keep in mind
The study's sample size may limit generalizability. Potential confounding factors were not fully controlled. The follow-up duration may not capture long-term effects.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Qing Z, Li Z, Yan G, Hua M, Yaping G, Guohong Z. The QCC Nursing Model Improves Blood Glucose Control in Type 2 Diabetes Patients. Journal of Medical Biochemistry. 2025;44(6):1288-1296. doi:10.5937/jomb0-55738
Efectos Principales
The EG demonstrated a significant decrease in fasting C-peptide levels by 1.5 ng/mL (p=0.01).
The EG showed a significant reduction in fasting plasma glucose levels by 2 mmol/L (p=0.02).
The EG had a significant improvement in glycated hemoglobin levels, decreasing by 0.5% (p=0.05).
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Insulin therapy, Usual care and C-peptide, Fasting Plasma Glucose (FPG), Fasting insulin levels, and 3 more.
This study contributes evidence to
Primary intervention
Insulin therapy
Primary outcomes
- C-peptide
- Fasting Plasma Glucose (FPG)
- Fasting insulin levels
Evidence topics
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
12
Evidence pairs
12
Relationships
3
Evidence topics
contributes_evidence
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
Moderate contributionModerate confidenceNetwork score: 72
3
Related topics
12
Evidence pairs
573
Related studies
High relevance in at least one topic
Why it is useful
- Contributes to 12 evidence relationships
- Includes primary outcome data
- Linked to 3 direct semantic evidence topics
Topic contributions
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Agrega evidencia relacionada a tu Evidence Tracker
Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.
Evidencia principal
Relación de evidencia
Insulin Therapies and HbA1c
Evidencia relacionada
Relación de evidencia
Insulin Therapies and Insulin Resistance
Guardar evidencia
Relación de evidencia
Insulin Therapies and Fasting Glucose
Guardar evidencia
Core evidence
Study findings
The primary outcomes reported in this study.
Fasting insulin levels
Insulin therapy → Fasting insulin levels
Insulin therapy → Fasting insulin levels
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerFasting Plasma Glucose (FPG)
Insulin therapy → Fasting Plasma Glucose (FPG)
Insulin therapy → Fasting Plasma Glucose (FPG)
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Estudios de apoyo: Basado en 2 estudios
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 4 studies
- ImpactScore™
- 88
- Very Positive
- ConsistencyScore™
- 75
- consistent
Estudios de apoyo: Basado en 4 estudios
Add to Evidence TrackerPostprandial blood glucose
Insulin therapy → Postprandial blood glucose
Insulin therapy → Postprandial blood glucose
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerTreatment satisfaction
Insulin therapy → Treatment satisfaction
Insulin therapy → Treatment satisfaction
Evidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerFasting Plasma Glucose (FPG)
Usual care → Fasting Plasma Glucose (FPG)
Usual care → Fasting Plasma Glucose (FPG)
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 4 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Estudios de apoyo: Basado en 4 estudios
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 56
- Slightly Positive
- ConsistencyScore™
- 89
- consistent
Estudios de apoyo: Basado en 9 estudios
Add to Evidence TrackerPostprandial blood glucose
Usual care → Postprandial blood glucose
Usual care → Postprandial blood glucose
Evidence Intelligence™
- EvidenceScore™
- Moderate
- Score 69 · Based on 2 studies
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- 100
- consistent
Estudios de apoyo: Basado en 2 estudios
Add to Evidence TrackerEvidence Intelligence™
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ImpactScore™
- 50
- Neutral
- ConsistencyScore™
- unclear
- Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence TrackerEvidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
La Evidencia Sugiere
- Fasting plasma glucose decreased significantly by 2 mmol/L in the EG.
- Patient satisfaction in the EG was substantially higher than in the RG.
- Glycated hemoglobin improved by 0.5% in the EG group.
A quién se aplica
- Adults diagnosed with Type 2 diabetes.
- Patients requiring insulin therapy.
- Individuals seeking improved diabetes management strategies.
Tener en Cuenta
- Results may not apply to all diabetes populations.
- The intervention's effectiveness may vary based on individual patient characteristics.
- Further studies are needed to confirm long-term benefits.
Entre Líneas
- The study's sample size may limit generalizability.
- Potential confounding factors were not fully controlled.
- The follow-up duration may not capture long-term effects.
Evidence Library
Build your evidence library
Save research, organize studies, and quickly find important evidence again.
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Usual care and HbA1c, Insulin Therapies and HbA1c.
Relaciones de evidencia relacionadas
Explore in Evidence ExplorerThis study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Usual care → HbA1c
Behavioral & Lifestyle
Evidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 56
- Slightly Positive
- ConsistencyScore™
- 89
- consistent
Estudios de apoyo: Basado en 9 estudios
View evidenceMedications
Insulin Therapies → HbA1c
Medications
Evidence Intelligence™
- EvidenceScore™
- Strong
- Score 79 · Based on 4 studies
- ImpactScore™
- 88
- Very Positive
- ConsistencyScore™
- 75
- consistent
Estudios de apoyo: Basado en 4 estudios
View evidenceIncluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
HbA1c Evidence Hub
All studies measuring HbA1c
9 studies
outcome_hubMeasures HbA1c as a key outcome.
Usual care Evidence Hub
All studies on Usual care
9 studies
intervention_hubContributes to Usual care evidence base.
Insulin Therapies Evidence Hub
All studies on Insulin Therapies
4 studies
intervention_hubContributes to Insulin Therapies evidence base.
Recent Diabetes Research
Latest published studies
recency_collection
Published within the last 2 years.
Explora más en Evidence Explorer
Jump to pre-filtered views in Evidence Explorer.
All studies on Usual care and HbA1c
Intervention: Usual careOutcome: HbA1c
9 results
All studies on Insulin therapy and HbA1c
Intervention: Insulin therapyOutcome: HbA1c
4 results
All studies on Usual care
Intervention: Usual care
9 results
All studies on Insulin therapy
Intervention: Insulin therapy
4 results
All studies measuring HbA1c
Outcome: HbA1c
9 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Insulin Therapies improve HbA1c?
Strong Evidence
Insulin Therapies may improve HbA1c.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | strong positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on 9 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Insulin Therapies improve insulin resistance?
Strong Evidence
Insulin Therapies appears to improve Insulin Resistance.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Fasting insulin levels
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 7 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Insulin Therapies improve fasting glucose?
Strong Evidence
Insulin Therapies appears to improve Fasting Glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Fasting Plasma Glucose (FPG)
EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on 5 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Does Insulin Therapies improve postprandial and ogtt glucose?
Strong Evidence
Insulin Therapies appears to improve Postprandial and OGTT Glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
- 1
Postprandial blood glucose
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 4 supporting studies with consistent results and a positive effect signal.
Limitations
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Evidence topics
Follow the topics this study contributes to.
Explore in Evidence Explorer
Open broader Evidence Explorer views for this relationship.
Related research
Read related research summaries.
Semaglutide with Insulin Improves Diabetes Control and Kidney HealthEducational intervention improves glycemic control in type 2 diabetes patientsHRS-7535 improves glycemic control in adults with type 2 diabetesVildagliptin improves glycemic control in type 2 diabetes patients on insulinDigital intervention improves glycemic control in type 2 diabetes patients
Sin anuncios. Sin rastreo.
Centrada en la evidencia, no en la publicidad.
Segura y privada
Tus datos siempre están protegidos.
Siempre al día
Se agregan nuevos estudios todos los días.